Cellebrite Reports Strong Q1 2026 Results with 19% Revenue Growth and Positive Outlook

summarizeSummary

Cellebrite reported robust first-quarter 2026 financial results, including 19% revenue growth and 21% ARR growth, alongside positive guidance for the upcoming quarter and full year.

check_boxKey Events

• Strong Q1 2026 Financial Performance

  Reported revenue of $128.3 million, up 19% year-over-year, and non-GAAP diluted earnings per share of $0.12.

• Significant ARR Growth

  Achieved total Annual Recurring Revenue (ARR) of $493.0 million, representing a 21% year-over-year increase, with a recurring revenue dollar-based net retention rate of 115%.

• Positive Financial Outlook

  Provided Q2 2026 guidance with ARR expected between $510 million and $513 million (22%-23% growth) and full-year 2026 ARR guidance of $567 million to $573 million (18%-19% growth).

• Strategic Product Innovation

  Introduced Cellebrite Genesis, a new agentic AI product, and announced worldwide general availability of Guardian Investigate, an AI-powered investigative management solution.

auto_awesomeAnalysis

Cellebrite announced solid first-quarter 2026 financial results, demonstrating continued growth in revenue and annual recurring revenue (ARR). The company reported a 19% year-over-year increase in revenue to $128.3 million and a 21% rise in ARR to $493.0 million. Management also provided an optimistic outlook for Q2 and the full fiscal year 2026, projecting further acceleration in ARR expansion. These results, coupled with strategic product launches and key certifications like FedRAMP High Authorization, indicate strong operational execution and a positive trajectory for the company.